About TTK Healthcare Ltd
TTK Healthcare has five main Strategic Business Units namely, Pharmaceuticals (for Animal welfare), Consumer Products, Medical Devices, Foods and Protective Devices Divisions.
Founded
1958
CEO
T T Raghunathan
Employees
3,633
HQ
Chennai, Tamil Nadu
Finished Products
1Sale of Products
₹2,399.64Cr2discount
₹31.30Cr3Other Operating Revenue
₹11.92CrRaw Materials
1Raw Material Consumed
₹894.83Cr2Purchase of Stock-in-trade
₹886.21CrAbout TTK Healthcare Ltd
TTK Healthcare has five main Strategic Business Units namely, Pharmaceuticals (for Animal welfare), Consumer Products, Medical Devices, Foods and Protective Devices Divisions.
Founded:1958
CEO:T T Raghunathan
Employees:3,633
HQ:Chennai, Tamil Nadu
Finished Products
1Sale of Products
₹2,399.64Cr2discount
₹31.30Cr3Other Operating Revenue
₹11.92CrRaw Materials
1Raw Material Consumed
₹894.83Cr2Purchase of Stock-in-trade
₹886.21CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,216
52W Low
₹735
Volume27.90K
Avg VolumeN/A
Beta0.68
Dividend Yield0.89%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
21.58x
Valuation
P/B Ratio
1.44x
Valuation
EPS
₹52.34
Valuation
Dividend Yield
0.89%
Valuation
ROE
5.89%
Profitability
ROCE
7.50%
Profitability
Revenue by Segment
Contribution & growth by business line
Consumer Products
-1.5%28.1%
₹241.278 Cr
Protective Devices
+4.8%25.3%
₹216.508 Cr
Foods
+13.6%17.6%
₹151.1 Cr
Animal Welfare
+11.6%16.5%
₹141.084 Cr
Medical Devices
+18.6%12.5%
₹106.917 Cr
Others
+11.5%0.0%
₹0.395 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
93.6%
International
6.4%
India93.6%
Outside India6.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Sara Lee
United States
0.00% stakeL
London International
United Kingdom
0.00% stakeK
Kali Chemi
Germany
0.00% stakeH
Hatu-ICO
Spain
0.00% stakeN
Nicholas Kiwi
United States
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.